Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

IMI buys 75% of Instant Technologies for $44mm in cash/stock

Executive Summary

Continuing to strengthen its drugs-of-abuse diagnostic offerings, Inverness Medical Innovations (IMI) has acquired 75% of Instant Technologies for $43.7mm in cash and stock, paying nearly twice what the private company grossed in 2006 sales.
Deal Industry
  • In Vitro Diagnostics
    • Chemistry, Immunoassay
    • Saliva-based Testing
    • Urine-based Testing
Deal Status
  • Final
Deal Type
  • Acquisition
    • Partial Acquisition
    • Includes Contract
    • Payment Includes Stock
    • Payment Includes Cash

Related Companies